SinoMed, a Medical Device Company, Stages $50 Million IPO on the Shanghai STAR Exchange
publication date: Nov 4, 2019
Sino Medical Sciences completed an IPO on the Shanghai STAR Exchange last week, raising $50 million at a market capitalization of $412 million. The company makes high-end novel interventional medical devices for cardiovascular needs. Its products include drug eluting stents, balloon catheters, coronary stents and transcatheter mitral valve replacement kits. SinoMed's stock price rose as much as 217% in its first trading day. Founded in 2007, the company's headquarters and other operations, including R&D and production, are located in Tianjin. More details....
Stock Symbol: (SHA: 688108)
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.